Center for Scientific Review; Notice of Closed Meetings, 53113-53114 [2024-13839]
Download as PDF
<![CDATA[
53113
Federal Register / Vol. 89, No. 122 / Tuesday, June 25, 2024 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Type of collection
Average time
per response
(in hours)
Total annual
burden hours
Customer Satisfaction Surveys .......................................................................
In-Depth Interviews (IDIs) or Small Discussion Groups ..................................
Focus Groups ..................................................................................................
Usability and Pilot Testing ...............................................................................
Conference/Training—Pre-and Post-Surveys ..................................................
NIH-Wide Basic Abstract Form ........................................................................
NIH-Wide Basic Registration Form ..................................................................
1,000
1,000
1,000
150,000
100,000
50,000
75,000
1
1
1
1
2
1
1
30/60
90/60
90/60
5/60
10/60
1
3/60
500
1,500
1,500
12,500
33,333
50,000
3,750
Total ..........................................................................................................
378,000
478,000
........................
103,083
Dated: June 17, 2024.
Lawrence A. Tabak,
Principal Deputy Director, National Institutes
of Health.
[FR Doc. 2024–13914 Filed 6–24–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Amended
Notice of Meeting
Notice is hereby given of a change in
the meeting of the Center for Scientific
Review Special Emphasis Panel; Review
of AREA grants in Cell Biology,
Molecular Biology and Genetics, July
08, 2024, 09:00 a.m. to July 09, 2024,
07:00 p.m., National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892, which was
published in the Federal Register on
June 07, 2024, 89 FR 48659, Doc 2024–
12475.
This meeting is being amended to
change the meeting from a two-day
meeting to a one-day meeting on July 8,
2024, from 9:00 a.m. to 7:00 p.m. The
meeting is closed to the public.
Dated: June 18, 2024.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–13840 Filed 6–24–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
khammond on DSKJM1Z7X2PROD with NOTICES
Annual
frequency
per response
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
VerDate Sep<11>2014
17:03 Jun 24, 2024
Jkt 262001
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Social and Community Influences
Across the Lifecourse.
Date: July 15–16, 2024.
Time: 8:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Hybrid Meeting).
Contact Person: David E Pollio, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1006F,
Bethesda, MD 20892, (301) 594–4002,
polliode@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Microbial Diagnostics, Detection
and Decontamination.
Date: July 17–18, 2024.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites at the Chevy Chase
Pavilion, 4300 Military Road NW,
Washington, DC 20015.
Contact Person: Shinako Takada, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, 301–827–5997, shinako.takada@
nih.gov.
Name of Committee: Social and
Community Influences on Health Integrated
Review Group; Population and Public Health
Approaches to HIV/AIDS Study Section.
Date: July 17–18, 2024.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
PO 00000
Frm 00076
Fmt 4703
Sfmt 4703
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Aubrey S Madkour, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1000C,
Bethesda, MD 20892, (301) 594–6891,
madkouras@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; RFA:
Understanding Neurological Effects of
COVID–19 and Post-Acute Sequelae of
SARS–CoV–2 Infection.
Date: July 17–18, 2024.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Aleksey Gregory
Kazantsev, Ph.D., Scientific Review Officer,
Center for Scientific Review, National
Institutes of Health, 6701 Rockledge Drive,
Room 5201, Bethesda, MD 20892, (301) 435–
1042, aleksey.kazantsev@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Cancer
Diagnostics and Treatments (CDT).
Date: July 17–18, 2024.
Time: 9:00 a.m. to 7:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Victor A Panchenko,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 802B2,
Bethesda, MD 20892, (301) 867–5309,
victor.panchenko@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Clinical Care and Health
Interventions.
Date: July 17, 2024.
Time: 10:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Jacinta Bronte-Tinkew,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3164,
E:\FR\FM\25JNN1.SGM
25JNN1
khammond on DSKJM1Z7X2PROD with NOTICES
53114
Federal Register / Vol. 89, No. 122 / Tuesday, June 25, 2024 / Notices
MSC 7770, Bethesda, MD 20892, (301) 806–
0009, Jacinta.bronte-tinkew@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Bioengineering, Surgery,
Anesthesiology, and Trauma.
Date: July 17, 2024.
Time: 10:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Donald Scott Wright,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5108,
MSC 7854, Bethesda, MD 20892, (301) 435–
8363, wrightds@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Applied Immunology and Vaccine
Development.
Date: July 17–18, 2024.
Time: 10:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Dayadevi Jirage, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4422,
Bethesda, MD 20892, (301) 867–5309,
jiragedb@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Biology and Development of the
Eye.
Date: July 17, 2024.
Time: 11:30 a.m. to 4:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Jessica Smith, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, 301.402.3717, jessica.smith6@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Neuroendocrinology, Sleep, Alcohol
and Neurobiology of Motivated Behavior.
Date: July 17, 2024.
Time: 12:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Myongsoo Matthew Oh,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1011F,
Bethesda, MD 20892, (301) 435–1042,
ohmm@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Neuroimmunology, Glioma, Brain
Injury, and Anxiety Disorders.
Date: July 17, 2024.
Time: 12:00 p.m. to 7:00 p.m.
VerDate Sep<11>2014
17:03 Jun 24, 2024
Jkt 262001
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Vilen A. Movsesyan,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4040M,
MSC 7806, Bethesda, MD 20892, 301–402–
7278, movsesyanv@csr.nih.gov.
Name of Committee: Infectious Diseases
and Immunology B Integrated Review Group;
HIV Immunopathogenesis and Vaccine
Development Study Section.
Date: July 18–19, 2024.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health;
Rockledge II; 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Philip Owens, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Dr., Bethesda, MD
20892, (301) 594–7394, owensp2@csr.nih.gov.
Name of Committee: Population Sciences
and Epidemiology Integrated Review Group;
Aging, Injury, Musculoskeletal, and
Rheumatologic Disorders Study Section.
Date: July 18–19, 2024.
Time: 10:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Nketi I Forbang, MD, MPH,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1006K1,
Bethesda, MD 20892, (301) 594–0357,
forbangni@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: June 18, 2024.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–13839 Filed 6–24–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HOMELAND
SECURITY
Coast Guard
[Docket No. USCG–2024–0184]
Collection of Information Under
Review by Office of Management and
Budget; OMB Control Number 1625–
0007
Coast Guard, DHS.
Thirty-day notice requesting
comments.
AGENCY:
ACTION:
PO 00000
Frm 00077
Fmt 4703
Sfmt 4703
In compliance with the
Paperwork Reduction Act of 1995 the
U.S. Coast Guard is forwarding an
Information Collection Request (ICR),
abstracted below, to the Office of
Management and Budget (OMB), Office
of Information and Regulatory Affairs
(OIRA), requesting an extension of its
approval for the following collection of
information: 1625–0007, Characteristics
of Liquid Chemicals Proposed for Bulk
Water Movement; without change.
Our ICR describes the information we
seek to collect from the public. Review
and comments by OIRA ensure we only
impose paperwork burdens
commensurate with our performance of
duties.
DATES: You may submit comments to
the Coast Guard and OIRA on or before
July 25, 2024.
ADDRESSES: Comments to the Coast
Guard should be submitted using the
Federal eRulemaking Portal at https://
www.regulations.gov. Search for docket
number [USCG–2024–0184]. Written
comments and recommendations to
OIRA for the proposed information
collection should be sent within 30 days
of publication of this notice to https://
www.reginfo.gov/public/do/PRAMain.
Find this particular information
collection by selecting ‘‘Currently under
30-day Review—Open for Public
Comments’’ or by using the search
function.
A copy of the ICR is available through
the docket on the internet at https://
www.regulations.gov. Additionally,
copies are available from:
COMMANDANT (CG–6P), ATTN:
PAPERWORK REDUCTION ACT
MANAGER, U.S. COAST GUARD, 2703
MARTIN LUTHER KING JR. AVE. SE,
STOP 7710, WASHINGTON, DC 20593–
7710.
FOR FURTHER INFORMATION CONTACT: A.L.
Craig, Office of Privacy Management,
telephone 202–475–3528, fax 202–372–
8405, or email hqs-dg-m-cg-61-pii@
uscg.mil for questions on these
documents.
SUPPLEMENTARY INFORMATION:
SUMMARY:
Public Participation and Request for
Comments
This notice relies on the authority of
the Paperwork Reduction Act of 1995;
44 U.S.C. 3501 et seq., chapter 35, as
amended. An ICR is an application to
OIRA seeking the approval, extension,
or renewal of a Coast Guard collection
of information (Collection). The ICR
contains information describing the
Collection’s purpose, the Collection’s
likely burden on the affected public, an
explanation of the necessity of the
Collection, and other important
E:\FR\FM\25JNN1.SGM
25JNN1
]]>Agencies
[Federal Register Volume 89, Number 122 (Tuesday, June 25, 2024)]
[Notices]
[Pages 53113-53114]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-13839]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Small Business: Social and Community Influences Across the
Lifecourse.
Date: July 15-16, 2024.
Time: 8:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Hybrid Meeting).
Contact Person: David E Pollio, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1006F, Bethesda, MD 20892, (301)
594-4002, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Small Business: Microbial Diagnostics, Detection and
Decontamination.
Date: July 17-18, 2024.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Embassy Suites at the Chevy Chase Pavilion, 4300 Military
Road NW, Washington, DC 20015.
Contact Person: Shinako Takada, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD 20892, 301-827-5997,
[email protected].
Name of Committee: Social and Community Influences on Health
Integrated Review Group; Population and Public Health Approaches to
HIV/AIDS Study Section.
Date: July 17-18, 2024.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Aubrey S Madkour, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1000C, Bethesda, MD 20892, (301)
594-6891, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; RFA: Understanding Neurological Effects of COVID-19 and Post-
Acute Sequelae of SARS-CoV-2 Infection.
Date: July 17-18, 2024.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Aleksey Gregory Kazantsev, Ph.D., Scientific
Review Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5201, Bethesda, MD 20892, (301)
435-1042, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Cancer Diagnostics and Treatments (CDT).
Date: July 17-18, 2024.
Time: 9:00 a.m. to 7:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Victor A Panchenko, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 802B2, Bethesda, MD 20892, (301)
867-5309, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Clinical Care and Health Interventions.
Date: July 17, 2024.
Time: 10:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Jacinta Bronte-Tinkew, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3164,
[[Page 53114]]
MSC 7770, Bethesda, MD 20892, (301) 806-0009, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Bioengineering, Surgery, Anesthesiology, and
Trauma.
Date: July 17, 2024.
Time: 10:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Donald Scott Wright, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5108, MSC 7854, Bethesda, MD
20892, (301) 435-8363, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Small Business: Applied Immunology and Vaccine Development.
Date: July 17-18, 2024.
Time: 10:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Dayadevi Jirage, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4422, Bethesda, MD 20892, (301)
867-5309, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Biology and Development of the Eye.
Date: July 17, 2024.
Time: 11:30 a.m. to 4:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Jessica Smith, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892, 301.402.3717,
[email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Neuroendocrinology, Sleep, Alcohol and
Neurobiology of Motivated Behavior.
Date: July 17, 2024.
Time: 12:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Myongsoo Matthew Oh, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1011F, Bethesda, MD 20892, (301)
435-1042, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Neuroimmunology, Glioma, Brain Injury, and
Anxiety Disorders.
Date: July 17, 2024.
Time: 12:00 p.m. to 7:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Vilen A. Movsesyan, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4040M, MSC 7806, Bethesda, MD
20892, 301-402-7278, [email protected].
Name of Committee: Infectious Diseases and Immunology B
Integrated Review Group; HIV Immunopathogenesis and Vaccine
Development Study Section.
Date: July 18-19, 2024.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health; Rockledge II; 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Philip Owens, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Dr., Bethesda, MD 20892, (301) 594-7394,
[email protected].
Name of Committee: Population Sciences and Epidemiology
Integrated Review Group; Aging, Injury, Musculoskeletal, and
Rheumatologic Disorders Study Section.
Date: July 18-19, 2024.
Time: 10:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Nketi I Forbang, MD, MPH, Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1006K1, Bethesda, MD 20892, (301)
594-0357, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: June 18, 2024.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-13839 Filed 6-24-24; 8:45 am]
BILLING CODE 4140-01-P
